Compare STWD & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STWD | TFX |
|---|---|---|
| Founded | 2009 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.8B |
| IPO Year | 2009 | 1994 |
| Metric | STWD | TFX |
|---|---|---|
| Price | $15.67 | $130.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $20.00 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 3.6M | 499.6K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 10.64% | 1.02% |
| EPS Growth | ★ 4.55 | N/A |
| EPS | 0.15 | ★ 2.08 |
| Revenue | $1,844,289,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $283.44 | $15.97 |
| Revenue Next Year | $17.66 | $5.15 |
| P/E Ratio | $105.80 | ★ $65.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.49 | $100.18 |
| 52 Week High | $20.62 | $145.00 |
| Indicator | STWD | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 37.60 | 39.05 |
| Support Level | $15.50 | $128.36 |
| Resistance Level | $16.89 | $137.40 |
| Average True Range (ATR) | 0.26 | 4.21 |
| MACD | -0.02 | -0.81 |
| Stochastic Oscillator | 10.48 | 2.62 |
Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.